Option chain shows key data for XORTX Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for XORTX Therapeutics.

XORTX Therapeutics (NASDAQ:XRTX) Stock, Option Chain

XORTX Therapeutics

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Chi sale e chi scende: i maggiori movimenti nel pre-market di oggi

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ADSE

BCDA

BNRG

DELL

DLTH

EKSO

ESTC

FCUV

LGMK

LUCY

LUNR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MRVL

PALT

ULTA

VTAK

XRTX

Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Equities

Eurozone

Commodities

Intraday Update

AILE

ENSC

Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings

wall-street-ai17

Earnings

NVDA

Dow Jumps Over 100 Points; Nvidia Earnings Top Views

XORTX Therapeutics Inc

WIIM

XORTX Therapeutics shares are trading lower after the company announced it entered into a securities purchase agreement with institutional investors to sell 810,810 shares of common stock at $1.85 per share.

XORTX Enters Securities Purchase Agreements With Institutional Investors For Purchase And Sale Of 810,810 Shares At $1.85/Common Share

Shares of MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter financial results and<a href="https://www.benzinga.com/news/earnings/24/08/40639636/mongodb-stock-rallies-after-strong-q2-results-upbeat-guidance"> issued strong guidance</a>.
MongoDB reported quarterly earnings of 70 cents per share, which beat the analyst consensus estimate of 49 cents by 42.86%. Quarterly sales came in at $478.1 million, which beat the consensus estimate by 3.03% and represents growth of 12.82% from the same period last year.
MongoDB shares jumped 15.2% to $283.07 in the pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Brenmiller Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>) gained 96.2% to $1.32 in pre-market trading after the company reported a year-over-year increase in H1 EPS results. Also, the company announced a projected pipeline valued up to $500 million.</li>
<li>Focus Universal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) rose 52.2% to $0.2894 in today's pre-market trading after the company in a Form4 filing disclosed that CEO Desheng Wang bought 302,100 shares of stock at an average price of $0.18 per share.</li>
<li>Emergent BioSolutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) gained 29.4% to $11.54 in pre-market trading. Emergent BioSolutions&#8217; ACAM2000 vaccine gained the FDA nod for Mpox indication amidst rising public health crisis.</li>
<li>Maxeon Solar Technologies, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAXN#NASDAQ">MAXN</a>) gained 23% to $0.1283 in pre-market trading after dipping over 30% on Thursday.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) gained 16.8% to $5.63 in pre-market trading after the company was awarded a $116.9 million NASA contract to deliver six science and technology payloads to the Moon.</li>
<li>LogicMark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) gained 13.8% to $0.1855 in pre-market trading after declining 9% on Thursday.</li>
<li>Marvell Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) gained 8.8% to $76.00 in the pre-market trading session after the company reported its second-quarter financial results.</li>
<li>ADS-TEC Energy PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSE#NASDAQ">ADSE</a>) gained 6.5% to $14.00 in pre-market trading.</li>
<li>Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) rose 6.5% to $117.90 in pre-market trading after the company reported stronger-than-expected results for its second quarter.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Catheter Precision, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#NYSE">VTAK</a>) shares declined 35.3% to $0.88 in pre-market trading after dipping 23% on Thursday.</li>
<li>Elastic N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) shares fell 27.1% to $75.60 in pre-market trading after the company reported first-quarter financial results and issued second-quarter revenue guidance below estimates.</li>
<li>BioCardia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) fell 20.3% to $3.20 in pre-market trading. BioCardia shares jumped 83% on Wednesday after FDA cleared the company to market its Morph DNA Steerable Introducer product family.</li>
<li>XORTX Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) fell 13.3% to $2.34 in pre-market trading after surging over 130% on Thursday.</li>
<li>Ekso Bionics Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) shares fell 10.7% to $1.00 in pre-market trading. Ekso Bionics priced its $6 million underwritten public offering of 6m units with dual warrants.</li>
<li>Paltalk, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALT#NASDAQ">PALT</a>) fell 10.4% to $4.89 in today's pre-market trading after gaining 14% on Thursday.</li>
<li>Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) shares declined 8.8% to $4.64 in pre-market trading. Innovative Eyewear shares jumped 54% on Thursday after the company announced that its Lucyd Lyte frames are now being sold on Target.com.</li>
<li>Duluth Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) shares fell 8.6% to $3.51 in pre-market trading. Duluth Holdings shares jumped around 19% on Thursday after the company reported better-than-expected second-quarter sales results.</li>
<li>Autozi Internet Technology (Global) Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZI#NASDAQ">AZI</a>) shares dipped 6.9% to $2.70 in pre-market trading after gaining over 10% on Thursday. Autozi Internet Technology (Global) announced the closing of initial public offering.</li>
<li>Ulta Beauty, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) declined 6.4% to $344.03 in pre-market trading after the company reported weaker-than-expected results for its second quarter and cut its FY24 guidance.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/08/40624754/top-2-materials-stocks-that-are-ticking-portfolio-bombs">Top 2 Materials Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 200 points on Thursday.
The Dow traded up 1.03% to 41,513.10 while the NASDAQ rose 1.15% to 17,758.29. The S&amp;P 500 also rose, gaining, 0.88% to 5,641.47.
Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40622821/top-3-tech-stocks-youll-regret-missing-this-month"> Top 3 Tech Stocks You&#8217;ll Regret Missing This Month</a>
Leading and Lagging Sectors Industrials shares climbed by 1.4% on Thursday.
In trading on Thursday, real estate shares fell by 0.6%.
Top Headline
Best Buy Co., Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) reported better-than-expected second-quarter financial results raised its FY25 earnings guidance on Thursday.
Best Buy reported fiscal second-quarter adjusted EPS of $1.34, beating the street view of $1.16. Quarterly sales of $9.29 billion beat the analyst consensus of $9.24 billion. The stock gained after the print.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BioCardia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares shot up 43% to $3.1401 after FDA cleared the company to market its Morph DNA Steerable Introducer product family.</li>
<li>Shares of Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) got a boost, surging 80% to $5.95 after the company announced that its Lucyd Lyte frames are now being sold on Target.com.</li>
<li>XORTX Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) shares were also up, gaining 85% to $2.1755. XORTX highlighted Pioneering Research indicating a role for genetic regulation of Xanthine Oxidase and Therapeutic targeting of aberrant purine metabolism.</li>
</ul>
Equities Trading DOWN
<ul>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares dropped 57% to $1.3695 after Hindenburg issued a short report on the stock.</li>
<li>Shares of Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) were down 29% to $0.4463 after the company announced a $5 million registered direct offering and concurrent private placement.</li>
<li>Big Lots, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIG#NYSE">BIG</a>) was down, falling 41% to $0.5534 after a report suggesting the company is considering a bankruptcy filing.</li>
</ul>
Commodities In commodity news, oil traded up 1.8% to $75.88 while gold traded up 0.7% at $2,556.10.
Silver traded up 2.4% to $29.905 on Thursday, while copper fell 0.1% to $4.2130.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.76%, Germany's DAX rose 0.69% and France's CAC 40 rose 0.84%. Spain's IBEX 35 Index rose 0.23%, while London's FTSE 100 rose 0.43%.
Annual inflation rate in Germany eased to 1.9% in August from 2.3% in July. The consumer confidence indicator in the Eurozone declined to -13.5 in August, versus earlier expectations of -13.4. The economic sentiment indicator in the Eurozone climbed to 96.6 in August from the revised 96 in the prior month
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 falling 0.02%, Hong Kong's Hang Seng Index gaining 0.53%, China's Shanghai Composite Index falling 0.50% and India's BSE Sensex rising 0.43%.
The consumer confidence index in Japan came in unchanged at 36.7 in August.
Economics
<ul>
<li>Core PCE prices in the U.S. increased by 2.8% from the prior quarter in the second, compared to market estimates of 2.9%.</li>
<li>U.S. initial jobless claims fell by 2,000 from the prior week to 231,000 in the period ending Aug. 24.</li>
<li>U.S. real gross domestic product expanded at an annual rate of 3.0% in the second quarter, up from 1.4% in the first quarter.</li>
<li>The U.S. trade deficit in goods increased to $102.7 billion in July versus a revised $96.6 billion gap in the prior month.</li>
<li>U.S. wholesale inventories rose by 0.3% month-over-month to $905 billion in July, versus a revised 0.2% gain in the earlier month.</li>
<li>U.S. natural gas stocks rose 35 billion cubic feet during the week that ended Aug. 23.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40624711/cisco-target-and-2-other-stocks-executives-are-selling">Cisco, Target And 2 Other Stocks Executives Are Selling</a></li>
</ul>

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 100 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.28% to 41,206.85 while the NASDAQ rose 0.73% to 17,683.80. The S&amp;P 500 also rose, gaining, 0.44% to 5,616.60.
Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/08/40622821/top-3-tech-stocks-youll-regret-missing-this-month"> Top 3 Tech Stocks You&#8217;ll Regret Missing This Month</a>
Leading and Lagging Sectors Consumer discretionary shares climbed by 0.8% on Thursday.
In trading on Thursday, real estate shares fell by 0.5%.
Top Headline
Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) reported better-than-expected earnings and sales results for its second quarter on Wednesday.
The company issued above-consensus third-quarter revenue guidance and announced a $50-billion additional stock repurchase authorization. However, the gross margin contracted from the first quarter.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>BioCardia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) shares shot up 85% to $4.06 after FDA cleared the company to market its Morph DNA Steerable Introducer product family.</li>
<li>Shares of Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) got a boost, surging 90% to $6.30 after the company announced that its Lucyd Lyte frames are now being sold on Target.com.</li>
<li>XORTX Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) shares were also up, gaining 41% to $1.6499. XORTX highlighted Pioneering Research indicating a role for genetic regulation of Xanthine Oxidase and Therapeutic targeting of aberrant purine metabolism.</li>
</ul>
Equities Trading DOWN
<ul>
<li>iLearningEngines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AILE#NASDAQ">AILE</a>) shares dropped 51% to $1.5498 after Hindenburg issued a short report on the stock.</li>
<li>Shares of Ensysce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSC#NASDAQ">ENSC</a>) were down 36% to $0.4035 after the company announced a $5 million registered direct offering and concurrent private placement.</li>
<li>Big Lots, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIG#NYSE">BIG</a>) was down, falling 35% to $0.59 after a report suggesting the company is considering a bankruptcy filing.</li>
</ul>
Commodities In commodity news, oil traded up 2.5% to $76.39 while gold traded up 0.3% at $2,545.60.
Silver traded up 1.4% to $29.635 on Thursday, while copper fell 0.5% to $4.1955.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.7%, Germany's DAX rose 0.7% and France's CAC 40 rose 0.8%. Spain's IBEX 35 Index rose 0.4%, while London's FTSE 100 rose 0.4%.
Annual inflation rate in Germany eased to 1.9% in August from 2.3% in July. The consumer confidence indicator in the Eurozone declined to -13.5 in August, versus earlier expectations of -13.4. The economic sentiment indicator in the Eurozone climbed to 96.6 in August from the revised 96 in the prior month
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 falling 0.02%, Hong Kong's Hang Seng Index gaining 0.53%, China's Shanghai Composite Index falling 0.50% and India's BSE Sensex rising 0.43%.
The consumer confidence index in Japan came in unchanged at 36.7 in August.
Economics
<ul>
<li>Core PCE prices in the U.S. increased by 2.8% from the prior quarter in the second, compared to market estimates of 2.9%.</li>
<li>U.S. initial jobless claims fell by 2,000 from the prior week to 231,000 in the period ending Aug. 24.</li>
<li>U.S. real gross domestic product expanded at an annual rate of 3.0% in the second quarter, up from 1.4% in the first quarter.</li>
<li>The U.S. trade deficit in goods increased to $102.7 billion in July versus a revised $96.6 billion gap in the prior month.</li>
<li>U.S. wholesale inventories rose by 0.3% month-over-month to $905 billion in July, versus a revised 0.2% gain in the earlier month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40624711/cisco-target-and-2-other-stocks-executives-are-selling">Cisco, Target And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Shares of Science Applications International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/saic#NYSE">SAIC</a>) fell sharply during Monday&rsquo;s session after the company reported financial fourth-quarter EPS below estimates.
SAIC reported a 12% revenue decline Y/Y in the fourth quarter of fiscal 2024 to $1.74 billion, beating the consensus of $1.64 billion. Adjusted EPS of $1.43 was in line with the consensus.
Science Applications International shares dipped 10.7% to $127.29 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Canoo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/goev#NASDAQ">GOEV</a>) shares surged 95% to $3.77 after the US Department of Commerce has approved its Oklahoma City facility as a Foreign Trade Zone.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) shares jumped 71.9% to $2.9910 after surging around 34% on Friday. The company, last week, announced the pricing of a $3.85 million private placement.</li>
<li>Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) gained 53% to $0.6770, possibly on continued strength after it announced its Market.live launched Facebook and Instagram social shopping technology integration on Friday.</li>
<li>WaveDancer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wavd#NASDAQ">WAVD</a>) shares climbed 39.1% to $4.1461. WaveDancer and Firefly Neuroscience each received the requisite stockholder approvals required to consummate the merger between both companies.</li>
<li>Brand Engagement Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnai#NASDAQ">BNAI</a>) climbed 33.7% to $14.14 after jumping 40% on Friday.</li>
<li>Wearable Devices Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wlds#NASDAQ">WLDS</a>) climbed 31.6% to $0.5863. Wearable Devices published a report by its XR team suggesting &#39;The Mudra Band Can Be The Neural Bridge For Apple And Meta In Their Next Wave Of Smart Glasses Interaction.&#39;</li>
<li>Leafly Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfly#NASDAQ">LFLY</a>) rose 30.3% to $2.86.</li>
<li>Immuneering Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrx#NASDAQ">IMRX</a>) surged 30.3% to $2.49. Immuneering recently announced topline result from the ongoing Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors.</li>
<li>Nuvei Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvei#NASDAQ">NVEI</a>) rose 25.8% to $27.24 after the company said it was evaluating offers to go private.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gwav#NASDAQ">GWAV</a>) surged 25.4% to $0.38.</li>
<li>Fresh2 Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fres#NASDAQ">FRES</a>) gained 20.5% to $0.60.</li>
<li>NuScale Power Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) rose 21% to $9.50. Canaccord Genuity analyst George Gianarikas maintained NuScale Power with a Buy and raised the price target from $4.25 to $8.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 17% to $17.90 after the company reportedly began selling its EH216-S flying taxi on Taobao.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) gained 16.6% to $1.34. AEye is expected to release its financial results for the fourth quarter after the closing bell on March 26, 2024.</li>
<li>Aurora Cannabis Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) rose 16% to $3.69 after surging 10% on Friday.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) surged 15.9% to $5.47.</li>
<li>Latham Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swim#NASDAQ">SWIM</a>) gained 15.7% to $3.32 after Stifel upgraded the stock from Hold to Buy and raised its price target from $3 to $4.</li>
<li>2seventy bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsvt#NASDAQ">TSVT</a>) climbed 13% to $4.52. The FDA Advisory Committee voted in favor of Bristol Myers Squibb&#39;s and 2seventy Bio&#39;s Abecma for triple-class exposed multiple myeloma in earlier lines of therapy.</li>
<li>Global Gas Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hgas#NASDAQ">HGAS</a>) shares rose 11.5% to $1.7399 after falling 25% on Friday.</li>
<li>D-Wave Quantum Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qbts#NYSE">QBTS</a>) gained 10.6% to $2.3005. D-Wave Quantum said it is expanding its executive team to supercharge both its go-to-market growth strategy and product innovation.</li>
<li>Tilray Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>) surged 9.8% to $1.9001.</li>
<li>Graphjet Technology Sdn. Bhd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gti#NASDAQ">GTI</a>) rose 9.3% to $12.90.</li>
<li>Alphabet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) gained 6.3% to $150.09 following reports suggesting Apple Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) is in discussions to integrate Google <a href="https://www.benzinga.com/money/gemini-review/">Gemini</a> into iPhones.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Global Mofy Metaverse Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmm#NASDAQ">GMM</a>) shares dipped 33.7% to $1.9503.</li>
<li>Sonder Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sond#NASDAQ">SOND</a>) fell 33% to $3.68 after the company announced a delay to its fourth quarter and full year 2023 financial results announcement, and issued fourth quarter and full year 2023 preliminary highlights.</li>
<li>Veritone, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veri#NASDAQ">VERI</a>) dipped 21.2% to $3.06.</li>
<li>Worksport Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wksp#NASDAQ">WKSP</a>) fell 20.3% to $0.59 after the company announced pricing of $2.8 million registered direct offering &amp; concurrent private placement.</li>
<li>ReTo Eco-Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reto#NASDAQ">RETO</a>) dipped 20% to $1.56.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) declined 19.8% to $1.3469. TCBP announced exercise of Series D warrants for cash.</li>
<li>Solowin Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swin#NASDAQ">SWIN</a>) dipped 19.1% to $8.90 after reporting unaudited financial results for the first six months of fiscal year 2024.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) declined 15.5% to $4.3750.</li>
<li>JOANN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/joan#NASDAQ">JOAN</a>) shares fell 15.4% to $0.1949 after the company announced that it entered into an agreement to reduce its debt and receive $132 million in new capital and related financial accommodations.</li>
<li>CARGO Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crgx#NASDAQ">CRGX</a>) fell 15% to $26.65.</li>
<li>Chijet Motor Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cjet#NASDAQ">CJET</a>) shares tumbled 12.2% to $0.43 after gaining 52% on Friday.</li>
<li>Legacy Housing Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/legh#NASDAQ">LEGH</a>) fell 11.7% to $22.25 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) fell 11.5% to $15.56. B. Riley Financial failed to file its audited results after the end of extension period.</li>
<li>Getty Images Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gety#NYSE">GETY</a>) dipped 11.1% to $4.5950. Getty Images recently reported better-than-expected fourth-quarter financial results and issued FY24 revenue guidance.</li>
<li>GeneDx Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wgs#NASDAQ">WGS</a>) fell 11.1% to $ 10.68.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) dipped 10.5% to $1.97 after jumping 38% on Friday.</li>
<li>Summit Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smmt#NASDAQ">SMMT</a>) dipped 9.8% to $ 4.1650.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) fell 9.8% to $6.27 after gaining 10% on Friday.</li>
<li>Li Auto Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/li#NASDAQ">LI</a>) declined 9.7% to $34.11 after gaining around 3% on Friday.</li>
<li>Shift4 Payments, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/four#NASDAQ">FOUR</a>) fell 9.2% to $70.37. The company&rsquo;s CEO Jared Isaacman said bids from potential contenders failed to sufficiently value the firm, according to Bloomberg News.</li>
<li>Logitech International S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/logi#NASDAQ">LOGI</a>) shares fell 8.1% to $87.06 after the company announced the departure of CFO Chuck Boynton and reaffirmed 2024 financial guidance.</li>
<li>Hertz Global Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/htz#NASDAQ">HTZ</a>) fell 8% to $6.97.</li>
<li>Roblox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rblx#NYSE">RBLX</a>) fell 6.5% to $36.68.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) dipped 6.4% to $3.6550 after Raymond James downgraded the stock from Market Perform to Underperform.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37783078/bitcoin-tops-68-000-dogwifhat-emerges-as-top-gainer"> Bitcoin Tops $68,000; dogwifhat Emerges As Top Gainer </a>

Penny Stocks

Small Cap

AAPL

BNAI

CJET

CRGX

FOUR

FRES

GETY

GOEV

GOOGL

GWAV

HGAS

IMRX

JOAN

LEGH

LFLY

LIDR

LOGI

NBTX

NVEI

NYCB

QBTS

QRTEB

RBLX

RETO

RILY

SAIC

SMMT

SOND

SWIM

SWIN

TCBP

TLRY

TSVT

VERB

VERI

WAVD

WKSP

WLDS

Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of United Natural Foods, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/unfi#NYSE">UNFI</a>) fell sharply during Wednesday&rsquo;s session following <a href="https://www.benzinga.com/quote/UNFI/earnings">second-quarter results.</a>
United Natural Foods posted adjusted earnings of 7 cents per share, compared to market estimates for a loss of 1 cent per share. The company&rsquo;s quarterly sales came in at $7.78 billion, versus expectations of $7.87 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
United Natural Foods named Giorgio Matteo Tarditi as President and Chief Financial Officer.
United Natural Foods shares dipped 15.2% to $12.61 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) shares jumped 115.2% to $4.24. Rail Vision announced first commercial installation of its AI-driven main line systems in a national railways line.</li>
<li>Aptorum Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apm#NASDAQ">APM</a>) shares climbed 90.1% to $3.1750. Aptorum Group announced an agreement and plan of merger with YOOV Group Holding Ltd and a split-off agreement to separate its legacy business.</li>
<li>NKGen Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkgn#NASDAQ">NKGN</a>) gained 46.5% to $1.35.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) rose 39.2% to $11.19 after the company announced a special cash dividend of $8 per share.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) shares climbed 37.8% to $6.82. Airship AI Holdings shares jumped 200% on Tuesday after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) rose 33% to $0.9854 after gaining 42% on Tuesday.</li>
<li>American Public Education, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apei#NASDAQ">APEI</a>) gained 31.8% to $14.99 following upbeat quarterly results.</li>
<li>Dada Nexus Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dada#NASDAQ">DADA</a>) climbed 30.6% to $2.5740. Dada Nexus said certain revenues and associated costs were overstated in past financial statements.</li>
<li>Cemtrex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cetx#NASDAQ">CETX</a>) gained 30% to $4.4361. Cemtrex announced beta release of pioneering AI gun detection feature.</li>
<li>Wave Life Sciences Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wve#NYSE">WVE</a>) gained 28.5% to $6.16 following upbeat quarterly results.</li>
<li>Vincerx Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vinc#NASDAQ">VINC</a>) shares gained 24.5% to $6.89. Vincerx will present three posters at the American Association for Cancer Research (AACR) Annual Meeting 2024.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) rose 24.2% to $5.85.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) gained 23.8% to $14.72.</li>
<li>Lantern Pharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ltrn#NASDAQ">LTRN</a>) gained 22.6% to $5.90.</li>
<li>Energem Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/encp#NASDAQ">ENCP</a>) rose 22.4% to $8.31. Energem&rsquo;s merger partner recently said it accelerated the timeline for its planned manufacturing plant in Malaysia.</li>
<li>Cerus Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cers#NASDAQ">CERS</a>) gained 22.4% to $2.4350 after the company reported better-than-expected fourth-quarter GAAP EPS results.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) jumped 22.4% to $6.40.</li>
<li>Genprex, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnpx#NASDAQ">GNPX</a>) rose 22.1% to $5.03.</li>
<li>BeyondSpring Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bysi#NASDAQ">BYSI</a>) gained 21% to $3.5098.</li>
<li>Crexendo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cxdo#NASDAQ">CXDO</a>) surged 20% to $6.43 following upbeat quarterly results.</li>
<li>CrowdStrike Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crwd#NASDAQ">CRWD</a>) shares gained 17.2% to $348.73 after the company reported better-than-expected fourth-quarter earnings and revenues and issued upbeat guidance for FY25.</li>
<li>Fulcrum Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fulc#NASDAQ">FULC</a>) rose 17.2% to $12.85.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) gained 17% to $25.08 after the company reported fourth-quarter results above estimates, a new buyback approval and annual cash dividend.</li>
<li>Hippo Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hipo#NASDAQ">HIPO</a>) rose 14.6% to $16.58 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>Root, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/root#NASDAQ">ROOT</a>) rose 13.7% to $44.46.</li>
<li>Super Group (SGHC) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sghc#NYSE">SGHC</a>) surged 10.1% to $3.4350 following fourth-quarter results.</li>
<li>Infinera Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) gained 10% to $5.66. Infinera announced availability of next generation multi-haul optical line system functionality for industry-leading GX series platform.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 10% to $1,156.87. MicroStrategy shares fell over 21% on Tuesday after the company announced a proposed private offering of $600 million of convertible senior notes.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) gained 9.4% to $18.45.</li>
<li>Couchbase, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/base#NASDAQ">BASE</a>) shares rose 9.2% to $29.37 after the company reported upbeat fourth-quarter sales and issued upbeat revenue guidance for the first quarter.</li>
<li>NIO Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nio#NYSE">NIO</a>) gained 5.9% to $5.80. On Tuesday, NIO reported fourth-quarter revenue of 17.10 billion yuan ($2.41 billion), up by 6.5% year-over-year and down by 10.3% from the previous quarter.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Entravision Communications Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/evc#NYSE">EVC</a>) shares fell 51.1% to $1.7450 after the company received communication from Meta indicating its intention to wind down its ASP program globally, ending its relationship with all ASPs, including Entravision, by July 1. The ASP program represented a large portion of Entravision&#39;s total consolidated revenue.</li>
<li>Neptune Wellness Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nept#NASDAQ">NEPT</a>) fell 46.4% to $0.20. Neptune announced decision of Nasdaq Hearings Panel to delist common shares.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) fell 45% to $1.6499 after the company announced pricing of a $2.5 million registered direct offering and a concurrent private placement.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) fell 30.5% to $3.6550</li>
<li>Heart Test Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hscs#NASDAQ">HSCS</a>) fell 29% to $0.1272. HeartSciences announced Canada patent grant covering MyoVista Wavelet Technology.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) shares fell 26.7% to $0.0924 after dipping around 12% on Tuesday.</li>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) dipped 25.8% to $0.0620.</li>
<li>Affimed N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afmd#NASDAQ">AFMD</a>) fell 22.3% to $0.52 after the company announced a 1-for-10 reverse stock split.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares fell 21.8% to $11.49. Phunware shares jumped over 18% on Tuesday amid volatility in Trump-related stocks after Donald Trump won the North Dakota Caucus.</li>
<li>PureCycle Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pct#NASDAQ">PCT</a>) dipped 16.7% to $4.71 as the company announced a corporate update for the fourth quarter and fiscal year ending Dec. 31, 2023.</li>
<li>Nordstrom, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jwn#NYSE">JWN</a>) declined 14.6% to $17.83 after the company issued soft FY24 EPS guidance.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares fell 13.2% to $0.6510. Momentus recently received a flight and payload integration services contract from NASA. In another development, Momentus entered into a securities purchase agreement with a single U.S. institutional investor for the purchase and sale of 4.62 million shares of common stock at a purchase price of $0.865 per share and warrant pursuant to a registered direct offering, resulting in total gross proceeds of approximately $4.0 million.</li>
<li>Grifols, S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grfs#NASDAQ">GRFS</a>) fell 13.1% to $5.36 after declining around 7% on Tuesday.</li>
<li>THOR Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tho#NYSE">THO</a>) dipped 11.4% to $112.19 after the company reported a year-over-year decrease in second-quarter financial results and cut FY24 guidance below estimates.</li>
<li>TTEC Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttec#NASDAQ">TTEC</a>) fell 10.2% to $11.16 after Canaccord Genuity downgraded the stock from Buy to Hold and lowered its price target from $30 to $13.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) fell 10% to $32.40. On Tuesday, Dave reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>Brown-Forman Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bf-b#NYSE">BF-B</a>) fell 9.8% to $54.82 after the company reported worse-than-expected third-quarter revenue guidance. Also, the company expects its FY24 organic net sales to be flat.</li>
<li>SOPHiA GENETICS SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soph#NASDAQ">SOPH</a>) shares declined 9.8% to $5.05. Sophia Genetics recently reported worse than expected fourth-quarter earnings and issued 2024 guidance.</li>
<li>Xerox Holdings Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrx#NASDAQ">XRX</a>) fell 9.6% to $16.99 after the company announced a proposed convertible notes offering.</li>
<li>TAL Education Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tal#NYSE">TAL</a>) declined 8.9% to $12.02.</li>
<li>Valley National Bancorp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vly#NYSE">VLY</a>) dipped 8.5% to $7.20.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37502729/cramer-this-reit-is-a-little-too-dicey-as-for-marathon-digital-own-the-pure"> Cramer: This REIT Is &#39;A Little Too Dicey&#39;; As For Marathon Digital, &#39;Own The Pure&#39;</a>

AFMD

AISP

APEI

BASE

BF-B

BIAF

BYSI

CERS

CETX

CMAX

CRWD

CXDO

DADA

DAVE

ENCP

FULC

GNPX

GRFS

HIPO

HSCS

IFBD

INFN

JAGX

LTRN

LYFT

MEDS

MNTS

MSTR

NEPT

NKGN

OCEA

PHUN

ROOT

RVSN

SBFM

SGHC

SOPH

TTEC

UNFI

VINC

Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of SOPHiA GENETICS SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soph#NASDAQ">SOPH</a>) fell sharply during Tuesday&rsquo;s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Sophia Genetics posted GAAP loss of 37 cents per share, versus market expectations for a loss of 27 cents per share. The company&rsquo;s quarterly sales came in at $17.05 million, missing estimates of $17.33 million.
SOPHiA GENETICS shares tumbled 19% to $4.55 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Sunshine Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbfm#NASDAQ">SBFM</a>) climbed 146.3% to $0.1106 after dipping 19% on Monday. Sunshine Biopharma recently announced closing of $10.0 million underwritten public offering.</li>
<li>Airship AI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aisp#NASDAQ">AISP</a>) climbed 93.3% to $3.16 after the company announced that it has been awarded a contract with the Department of Justice for its Acropolis Enterprise Sensor Management video and data management platform.</li>
<li>Bruush Oral Care Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/brsh#NASDAQ">BRSH</a>) surged 42.9% to $0.0686.</li>
<li>Apogee Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apge#NASDAQ">APGE</a>) shares jumped 41.6% to $59.10 after the company announced interim results from its Phase 1 healthy volunteer trial for APG777. Also, the company reported FY23 financial results.</li>
<li>Dave Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dave#NASDAQ">DAVE</a>) gained 39.8% to $30.62 after the company reported a year-over-year increase in fourth-quarter revenue results.</li>
<li>CareMax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmax#NASDAQ">CMAX</a>) rose 38.1% to $10.65.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) gained 26.4% to $0.6571.</li>
<li>AeroVironment, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avav#NASDAQ">AVAV</a>) shares surged 24.8% to $163.05 after the company reported better-than-expected results for its fourth quarter. The company said it sees FY24 adjusted earnings of $2.69 to $2.83 per share on revenue of $700 million to $710 million.</li>
<li>INNOVATE Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vate#NASDAQ">VATE</a>) rose 24.4% to $0.90. The company reported fourth quarter financial results.</li>
<li>Ocean Biomedical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocea#NASDAQ">OCEA</a>) climbed 24.3% to $5.07.</li>
<li>Paymentus Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pay#NYSE">PAY</a>) rose gained 20.3% to $19.67 after the company reported better-than-expected fourth quarter financial results.</li>
<li>BeyondSpring Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bysi#NASDAQ">BYSI</a>) gained 20.1% to $1.97.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 19.4% to $2.83. bioAffinity Technologies reported accelerating sales growth of CyPath&reg; Lung.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) gained 18.4% to $4.18.</li>
<li>Cardio Diagnostics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdio#NASDAQ">CDIO</a>) rose 17.9% to $1.52 after the company announced that the U.S. Patent and Trademark Office issued a notice of allowance for U.S. Application No. 17,857,723 Titled Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.</li>
<li>Phunware, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phun#NASDAQ">PHUN</a>) shares rose 17.2% to $14.56. Phunware shares jumped 75% on Monday amid volatility in Trump-related stocks after Donald Trump won the Missouri and Idaho Republican caucuses. Also, the Supreme Court ruled that Colorado can&#39;t remove Donald Trump from the Republican primary ballot in the state.</li>
<li>3D Systems Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddd#NYSE">DDD</a>) jumped 14.7% to $4.7150. 3D Systems announced additional partial repurchase of convertible senior notes.</li>
<li>Fresenius Medical Care AG (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fms#NYSE">FMS</a>) gained 12.2% to $20.95. Fresenius Medical Care achieved next milestone in portfolio optimization program, announcing sale of dialysis clinics in Brazil, Colombia, Chile, Ecuador.</li>
<li>New York Community Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nycb#NASDAQ">NYCB</a>) gained 11.3% to $3.0411 after falling 23% on Monday. New York Community Bancorp last week announced that it identified material weaknesses in its internal controls and replaced its CEO.</li>
<li>Vicarious Surgical Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rbot#NYSE">RBOT</a>) rose 7.8% to $0.3880 after the company reported quarterly financial results.</li>
<li>DaVita Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>) gained 7.4% to $135.14. DaVita entered into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador.</li>
<li>Momentus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnts#NASDAQ">MNTS</a>) shares rose 7% to $0.8345 after the company was awarded a contract from NASA.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Quoin Pharmaceuticals, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qnrx#NASDAQ">QNRX</a>) shares fell 46.2% to $1.56 after the company announced the pricing of a $6.5 million public offering.</li>
<li>Crawford &amp; Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crd-a#NYSE">CRD-A</a>) fell 27.7% to $9.04 after the company reported worse-than-expected fourth-quarter financial results.</li>
<li>Ekso Bionics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ekso#NASDAQ">EKSO</a>) fell 24.8% to $1.58 after the company reported mixed fourth-quarter financial results.</li>
<li>ThredUp Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdup#NASDAQ">TDUP</a>) fell 23.3% to $1.8099 after reporting fourth-quarter results.</li>
<li>Lipella Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lipo#NASDAQ">LIPO</a>) fell 22.5% to $0.7909. Lipella Pharmaceuticals announced FDA clearance of IND for LP-410 for oral graft-versus-host disease, advancing clinical pipeline.</li>
<li>Kineta, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ka#NASDAQ">KA</a>) fell 21% to $0.7983.</li>
<li>Eyenovia, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eyen#NASDAQ">EYEN</a>) dipped 21% to $1.8006.</li>
<li>Semrush Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/semr#NYSE">SEMR</a>) fell 19.9% to $10.42 after the company reported fourth-quarter financial results.</li>
<li>BitFuFu Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fufu#NASDAQ">FUFU</a>) fell 19.3% to $10.60. BitFuFu shares jumped around 106% on Monday amid volatility following the company&#39;s recent business combination with Arisz Acquisition Corp and listing on the Nasdaq.</li>
<li>GitLab Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gtlb#NASDAQ">GTLB</a>) shares fell 19.2% to $60.16 after the company issued FY25 earnings guidance below estimates.</li>
<li>Sidus Space, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sidu#NASDAQ">SIDU</a>) declined 19.2% to $4.58.</li>
<li>Yiren Digital Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/yrd#NYSE">YRD</a>) fell 16.3% to $4.60.</li>
<li>Cara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cara#NASDAQ">CARA</a>) fell 16.2% to $0.8375 following downbeat fourth-quarter results.</li>
<li>Stitch Fix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfix#NASDAQ">SFIX</a>) shares dipped 15.7% to $2.7650 after the company reported worse-than-expected second-quarter financial results and issued a weak revenue forecast for FY24.</li>
<li>Lotus Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lot#NASDAQ">LOT</a>) fell 15.6% to $5.66.</li>
<li>Zhongchao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) fell 13.8% to $ 2.73.</li>
<li>CECO Environmental Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceco#NASDAQ">CECO</a>) dipped 13.8% to $19.74 despite better-than-expected fourth-quarter financial results and raised guidance.</li>
<li>Renalytix Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rnlx#NASDAQ">RNLX</a>) shares declined 13.5% to $1.27. Renalytix shares jumped 41% on Monday after the company announced that it received an unsolicited approach from a publicly listed strategic diagnostics company.</li>
<li>Powell Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/powl#NASDAQ">POWL</a>) tumbled 12.4% to $161.88.</li>
<li>Vivakor, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vivk#NASDAQ">VIVK</a>) shares fell 12.3% to $0.93 after jumping around 30% on Monday. Vivakor signed a definitive merger agreement with Empire Diversified Energy for a combined enterprise value of approximately $250 million.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares declined 12.1% to $1,172.93 after the company announced a proposed private offering of $600 million of convertible senior notes.</li>
<li>AxoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axgn#NASDAQ">AXGN</a>) fell 12.1% to $9.31 following fourth-quarter financial results.</li>
<li>MingZhu Logistics Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ygmz#NASDAQ">YGMZ</a>) shares fell 11.2% to $0.4785 after gaining over 12% on Monday. MingZhu Logistics Holdings signed a non-binding letter of intent (LOI) to acquire driverless auto technologies and intellectual property (IP) portfolio valued between $80 million and $90 million.</li>
<li>Albemarle Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alb#NYSE">ALB</a>) shares fell 11.9% to $117.40 after the company announced a proposed public offering of depositary shares.</li>
<li>Tandem Diabetes Care, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tndm#NASDAQ">TNDM</a>) dipped 11% to $27.73 after the company announced a proposed $250 million private placement of convertible notes due 2029.</li>
<li>Amer Sports, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/as#NYSE">AS</a>) fell 10.1% to $15.59 after the company reported worse-than-expected fourth-quarter adjusted EPS results and issued FY24 EPS guidance below estimates.</li>
<li>Ainos, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) shares fell 9.8% to $1.28 after surging 35% on Monday.</li>
<li>Samsara Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iot#NYSE">IOT</a>) fell 9% to $32.65.</li>
<li>MongoDB, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdb#NASDAQ">MDB</a>) fell 8.2% to $ 402.84.</li>
<li>Sprout Social, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spt#NASDAQ">SPT</a>) fell 8% to $58.96.</li>
<li>e.l.f. Beauty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elf#NYSE">ELF</a>) declined 7.5% to $193.29.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/24/03/37481565/top-5-materials-stocks-that-are-ticking-portfolio-bombs"> Top 5 Materials Stocks That Are Ticking Portfolio Bombs </a>

AIMD

APGE

AVAV

AXGN

BRSH

CARA

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CECO

CRD-A

EYEN

FUFU

GTLB

LIPO

POWL

QNRX

RBOT

RNLX

SEMR

SFIX

SIDU

TDUP

TNDM

VATE

VIVK

YGMZ

ZCMD

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

XORTX Therapeutics Inc. (&ldquo;XORTX&rdquo; or the &ldquo;Company&rdquo;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>, TSXV:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#TSXV">XRTX</a>, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce a second tranche closing (the &ldquo;Second Tranche Closing&rdquo;) of gross proceeds of CAD $224,850 under previously announced offering, including CAD $99,000 in a concurrent private placement of the Company in connection with international subscribers.

Offerings

TSXV:XRTX

XORTX Finalized $2.7M Prospectus Supplement and Concurrent Private Placement for the Offering of Units

Shares of Mobileye Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mbly#NASDAQ">MBLY</a>) fell sharply during Thursday&rsquo;s session after the company issued preliminary FY23 financial <a href="https://www.benzinga.com/news/earnings/24/01/36490653/why-system-software-company-mobileye-shares-are-diving-today">results and initial 2024 guidance</a>.
For the fourth quarter, the company expects revenue of $634 million-$638 million (vs. $636.39 million) and adjusted operating income of $241 million-$247 million. The company&#39;s previous implied guidance was $623 million-$648 million in revenue.
Wolfe Research analyst Shreyas Patil downgraded Mobileye Global from Outperform to Peer Perform.
Mobileye Global shares dipped 23.5% to $30.37 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Minim, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/minm#NASDAQ">MINM</a>) shares jumped 170.2% to $4.62.</li>
<li>Omega Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omga#NASDAQ">OMGA</a>) gained 92.7% to $5.26 after Novo Nordisk entered into a research collaboration with the company.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) shares climbed 65.8% to $0.2920 after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.</li>
<li>Jeffs&#39; Brands Ltd(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) gained 40% to $4.41 after surging 25% on Wednesday. Jeffs&#39; Brands, last month, signed non-binding letters of intent with Sky Growth Partners to invest in a DLP laser-based system for counter-drone solutions and laser-based wireless charging technology.</li>
<li>Mobix Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mobx#NASDAQ">MOBX</a>) gained 33.3% to $4.00. Mobix Labs was awarded 15-month contract to supply EMI filtered connectors as part of US Army&#39;s M-1 Abrams Tank Program.</li>
<li>ATIF Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atif#NASDAQ">ATIF</a>) jumped 30.6% to $1.32.</li>
<li>Adicet Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acet#NASDAQ">ACET</a>) surged 26.1% to $2.22. Adicet Bio issued corporate updates and highlighted upcoming priorities for its pipeline programs in 2024.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) gained 22.6% to $1.9999.</li>
<li>XORTX Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xrtx#NASDAQ">XRTX</a>) rose 21.7% to $2.97. Alliance Global Partners analyst James Molloy maintained XORTX Therapeutics with a Buy and raised the price target from $9 to $14.</li>
<li>Kintara Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktra#NASDAQ">KTRA</a>) climbed 20.1% to $0.1690 after falling over 11% on Wednesday. Kintara Therapeutics, last month, announced a review of strategic alternatives focused on maximizing stockholder value.</li>
<li>QuantumScape Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/qs#NYSE">QS</a>) gained 18.5% to $7.70.</li>
<li>The Arena Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aren#NYSE">AREN</a>) shares rose 16.8% to $2.44 after falling over 9% on Wednesday. Arena Group Board, last month, terminated employment of CEO Ross Levinsohn.</li>
<li>NuZee, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nuze#NASDAQ">NUZE</a>) gained 16.7% to $2.9999.</li>
<li>Keros Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kros#NASDAQ">KROS</a>) gained 15.7% to $47.72. Keros Therapeutics priced upsized $140 million public offering of 3.5 million common shares at $40 per share.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dyn#NASDAQ">DYN</a>) gained 14.6% to $16.92. Dyne Therapeutics announced an underwritten public offering of $175 million of common stock.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) rose 13.8% to $1.32.</li>
<li>MINISO Group Holding Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mnso#NYSE">MNSO</a>) gained 9.7% to $21.87.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) rose 8.4% to $0.8031. Nikola said it produced 42 and wholesaled 35 Class 8 Nikola Hydrogen Fuel Cell Vehicles for US and Canada customers in 2023.</li>
<li>Select Medical Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sem#NYSE">SEM</a>) gained 6.4% to $25.00. Select Medical announced potential separation of Concentra.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) shares fell 36% to $0.58 after the company announced pricing of $9.0 million public offering.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ejh#NASDAQ">EJH</a>) fell 33.2% to $0.9894.</li>
<li>OPKO Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opk#NASDAQ">OPK</a>) shares dipped 28% to $1.0799. OPKO Health disclosed a private offering of Convertible Senior Notes due 2029.</li>
<li>Hitek Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hkit#NASDAQ">HKIT</a>) tumbled 25.2% to $0.77.</li>
<li>Relmada Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rlmd#NASDAQ">RLMD</a>) declined 24% to $3.44 after the company issued a corporate update.</li>
<li>Nemaura Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmrd#NASDAQ">NMRD</a>) dipped 21.2% to $0.1009.</li>
<li>ABVC BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abvc#NASDAQ">ABVC</a>) shares fell 20.1% to $1.5395. ABVC BioPharma shares jumped over 60% on Wednesday after the company and its subsidiary received a milestone payment of 46 million shares from AiBtl BioPharma under a global licensing payment.</li>
<li>LifeMD, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lfmd#NASDAQ">LFMD</a>) fell 20.1% to $6.20.</li>
<li>Singularity Future Technology Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgly#NASDAQ">SGLY</a>) tumbled 18.3% to $0.47.</li>
<li>cbdMD, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ycbd#NYSE">YCBD</a>) dipped 16.1% to $0.8302.</li>
<li>RiskOn International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roi#NASDAQ">ROI</a>) shares fell 13.7% to $0.2536 after dipping around 35% on Wednesday.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) tumbled 13.6% to $6.59.</li>
<li>Pinstripes Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pnst#NYSE">PNST</a>) declined 13.1% to $7.13.</li>
<li>Avanos Medical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avns#NASDAQ">AVNS</a>) fell 12.9% to $18.91 after reporting preliminary Q4 and FY23 financial results.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) fell 11.5% to $5.49 after jumping around 153% on Wednesday.</li>
<li>Schnitzer Steel Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdus#NASDAQ">RDUS</a>) declined 9.8% to $26.61 following first-quarter results.</li>
<li>Evotec SE (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evo#NASDAQ">EVO</a>) shares declined 9.2% to $9.60. Evotec and Owkin announced an A.I.-powered integrated multi-target collaboration in oncology, immunology and inflammation.</li>
<li>Walgreens Boots Alliance, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) dipped 8.5% to $23.39 following quarterly results.</li>
<li>MultiPlan Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpln#NYSE">MPLN</a>) fell 7.3% to $1.3150. MultiPlan named Travis Dalton as President and CEO on March 1, 2024.</li>
<li>First Wave BioPharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fwbi#NASDAQ">FWBI</a>) shares fell 7.1% to $5.07. First Wave BioPharma shares jumped 43% on Wednesday after Roth MKM maintained a Buy rating on the stock and adjusted its target from $11 to $40.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) fell 4.8% to $2.9310.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36490884/bitcoin-rises-above-43-000-following-adp-data-beam-emerges-as-top-gainer"> Bitcoin Rises Above $43,000 Following ADP Data; Beam Emerges As Top Gainer</a>

ABVC

ACET

AREN

ATIF

ATUS

ATXI

AVNS

FWBI

HKIT

JFBR

KROS

Kintara Therapeutics, Inc. - Common Stock

KTRA

LFMD

MBLY

MINM

MNSO

MOBX

MPLN

NEXI

NKLA

NMRD

NUZE

OMGA

PNST

RDUS

RLMD

SGLY

SMFL

YCBD

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

XORTX Therapeutics shares are trading higher after Alliance Global Partners maintained a Buy rating on the stock and raised its price target from $9 to $14.

Alliance Global Partners analyst James Molloy maintains XORTX Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRTX#NASDAQ">XRTX</a>) with a Buy and raises the price target from $9 to $14.

Price Target

Analyst Ratings

Alliance Global Partners Maintains Buy on XORTX Therapeutics, Raises Price Target to $14

Comments

XORTX Therapeutics

XORTX Therapeutics (XRTX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga